Business Context and Reporting Period
This Form 8-K, filed by Insulet Corporation on September 6, 2016, serves as a current report to update the presentation of financial information originally contained in the Company's Form 10-K for the year ended December 31, 2015. The filing retrospectively revises consolidated financial statements for the years ended December 31, 2015, 2014, and 2013, as well as balance sheets as of December 31, 2015 and 2014.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it details a structural reclassification of financial data. The primary financial adjustment involves presenting the historic operations of the Neighborhood Diabetes business as discontinued operations. This reclassification affects the Consolidated Statements of Operations, Comprehensive Loss, Stockholder's Equity, and Cash Flows for the periods presented.
Material Changes Versus Prior Period
The material change reported is the reclassification of the Neighborhood Diabetes business, which was sold to Liberty Medical LLC in February 2016. Consequently, the Company has retrospectively revised its 2015 Form 10-K to reflect this business as discontinued operations for all periods presented (2013, 2014, and 2015). This update aligns the 2015 annual report with the presentation used in the Form 10-Q filings for the quarters ended March 31, 2016, and June 30, 2016.
Guidance, Outlook, and Management Commentary
This Form 8-K does not contain new guidance, outlook, or management commentary regarding future performance. The filing explicitly states that it does not reflect events or developments occurring subsequent to the original filing of the 2015 Form 10-K, other than the reclassification of the Neighborhood Diabetes business. Investors are directed to subsequent Form 10-Q filings and other 8-K reports for information on events occurring after the 2015 Form 10-K filing date.
Important Facts for Investor Verification
- The Neighborhood Diabetes business was sold to Liberty Medical LLC in February 2016.
- Historic financial statements for 2013, 2014, and 2015 have been restated to classify Neighborhood Diabetes as discontinued operations.
- Exhibits 99.1 through 99.5 supersede specific items in the 2015 Form 10-K to reflect these reclassifications.
- The filing does not update the Management's Discussion and Analysis (MD&A) for risks, events, or trends occurring after the original 2015 Form 10-K filing date.
- Specific financial metrics (revenue, net loss, cash flow) are not listed in this text; they must be reviewed in the attached exhibits (99.3, 99.4, 99.5) or the XBRL data (Exhibit 101).